Loading…
Sat Kartar Life (SATKARTAR)₹155.05+4.62%Pharmaceuticals
Sat Kartar Life is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 14.2 against a peer median of 22.1, and ROCE of 36.0% against a peer median of 12.1%, and latest-quarter sales growth of 26.7% against a peer median of 18.7%. By market cap it is #4 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ambalal Sarabhai Enterprises | 276 | 20.6 | 12.1 | 12.3 | 0.36 | 0.0 | 202 | 18 | 7.9 | −51.5 | vs SATKARTAR |
| Astal Laboratories | 263 | 17.3 | 9.0 | 8.0 | 0.15 | 0.0 | 249 | 15 | — | — | vs SATKARTAR |
| Everest Organics | 255 | 44.6 | 12.0 | 7.6 | 0.66 | 0.0 | 196 | 6 | 19.2 | −9.7 | vs SATKARTAR |
| Sat Kartar Life | 245 | 14.2 | 36.0 | 26.5 | 0.04 | 0.5 | 201 | 17 | 26.7 | 28.4 | — |
| BDH Industries | 240 | 22.1 | 19.9 | 14.8 | 0.03 | 1.2 | 96 | 11 | 62.8 | 15.6 | vs SATKARTAR |
| Zenotech Laboratories | 238 | — | 4.6 | −1.2 | 0.00 | 0.0 | 44 | −1 | 10.2 | −145.0 | vs SATKARTAR |
| Accretion Nutraveda | 237 | 47.2 | 27.8 | 25.1 | 0.12 | 0.0 | 34 | 5 | 80.4 | 56.1 | vs SATKARTAR |
| Accretion Pharmaceuticals | 225 | 23.3 | 28.9 | 27.6 | 0.23 | 0.0 | 89 | 10 | 18.2 | 13.9 | vs SATKARTAR |
| Gennex Laboratories | 218 | 11.2 | 11.0 | 9.2 | 0.36 | 0.0 | 173 | 21 | 16.5 | −6.8 | vs SATKARTAR |
| Sanjivani Paranteral | 214 | 28.8 | 18.0 | 15.6 | 0.30 | 0.3 | 69 | 7 | 33.3 | 44.2 | vs SATKARTAR |
| Kerala Ayurveda | 212 | — | −10.0 | −161.1 | 7.83 | 0.0 | 131 | −16 | 15.9 | −500.5 | vs SATKARTAR |
| Peer median | 238 | 22.1 | 12.1 | 12.3 | 0.23 | 0.0 | 131 | 10 | 18.7 | 3.6 |
Listed companies closest to Sat Kartar Life in Pharmaceuticals include Ambalal Sarabhai Enterprises, Astal Laboratories, Everest Organics, BDH Industries, Zenotech Laboratories, Accretion Nutraveda, Accretion Pharmaceuticals, Gennex Laboratories.
Ambalal Sarabhai Enterprises, with a market cap of ₹276 Cr.
Sat Kartar Life trades at a P/E of 14.2; the median of its peer set is 22.1. A P/E above or below the median is a description, not a judgement on value.
Sat Kartar Life's return on capital employed is 36.0%, above the peer median of 12.1%.